Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat
- PMID: 2724075
- DOI: 10.1002/jps.2600780303
Evaluation of drug delivery following the administration of magnetic albumin microspheres containing adriamycin to the rat
Abstract
The disposition of adriamycin following its intra-arterial administration in rats as a solution (control) or via magnetic albumin microspheres (treatment group) has been investigated. The rat tail was demarcated into three segments: T1, the pre-target site; T2, the target site; and T3, the post-target site. In both groups, 2.0 mg/kg of adriamycin HCl was injected into the ventral caudal artery in T1 through a T-piece cannula. A magnetic field of 8000 G was directed towards T2. The concentration of adriamycin was measured in the heart, kidney, liver, lung, serum, small intestine, spleen, T1, T2, and T3 as a function of time using an ion-pairing HPLC assay. Areas under the mean adriamycin concentration-time curves were used to determine two indices of drug delivery: the relative tissue exposure and targeting efficiency. It was demonstrated that the magnetically responsive albumin microspheres altered the tissue distribution of adriamycin in rats. Administration of drug via magnetic microspheres was shown to increase the relative drug exposure to both T2 and liver.
Similar articles
-
Comparative disposition of adriamycin delivered via magnetic albumin microspheres in presence and absence of magnetic field in rats.Life Sci. 1990;46(7):471-9. doi: 10.1016/0024-3205(90)90002-9. Life Sci. 1990. PMID: 2304381
-
Ultrastructural disposition of adriamycin-associated magnetic albumin microspheres in rats.J Pharm Sci. 1989 Apr;78(4):290-4. doi: 10.1002/jps.2600780406. J Pharm Sci. 1989. PMID: 2724092
-
Effect of carrier dose on the multiple tissue disposition of doxorubicin hydrochloride administered via magnetic albumin microspheres in rats.J Pharm Sci. 1989 Sep;78(9):745-8. doi: 10.1002/jps.2600780909. J Pharm Sci. 1989. PMID: 2585268
-
Drug targeting: magnetically responsive albumin microspheres--a review of the system to date.Gynecol Oncol. 1981 Aug;12(1):1-13. doi: 10.1016/0090-8258(81)90089-5. Gynecol Oncol. 1981. PMID: 7024051 Review. No abstract available.
-
Albumin microspheres as drug carriers.Crit Rev Ther Drug Carrier Syst. 1985;2(1):19-63. Crit Rev Ther Drug Carrier Syst. 1985. PMID: 3913529 Review.
Cited by
-
Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole.Pharm Res. 1992 Mar;9(3):390-7. doi: 10.1023/a:1015803321609. Pharm Res. 1992. PMID: 1614973
-
Magnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation.Mol Pharm. 2009 Sep-Oct;6(5):1290-306. doi: 10.1021/mp900018v. Mol Pharm. 2009. PMID: 19591456 Free PMC article. Review.
-
In vivo restoration of dystrophin expression in mdx mice using intra-muscular and intra-arterial injections of hydrogel microsphere carriers of exon skipping antisense oligonucleotides.Cell Death Dis. 2022 Sep 9;13(9):779. doi: 10.1038/s41419-022-05166-0. Cell Death Dis. 2022. PMID: 36085138 Free PMC article.
-
Tissue distribution of methotrexate following administration as a solution and as a magnetic microsphere conjugate in rats bearing brain tumors.J Neurooncol. 1995;24(2):143-52. doi: 10.1007/BF01078484. J Neurooncol. 1995. PMID: 7562001
-
Preparation of adriamycin magnetic albumin microspheres and their experimental antitumor effects in vitro and in vivo.J Tongji Med Univ. 1999;19(4):295-9. doi: 10.1007/BF02886967. J Tongji Med Univ. 1999. PMID: 12938522
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources